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Abstract 15 
Microbial desulfurization or biodesulfurization (BDS) of fuels is a promising technology because 16 
it can desulfurize compounds that are recalcitrant to the current standard technology in the oil 17 
industry.  One of the obstacles to the commercialization of BDS is the reduction in biocatalyst 18 
activity concomitant with the accumulation of the end product 2-hydroxybiphenyl (HBP) during 19 
the process.  BDS experiments were performed by incubating Rhodococcus erythropolis IGTS8 20 
resting cell suspensions with hexadecane at 0.50 vol/vol containing 10 mM dibenzothiophene.  21 
The resin Dowex® Optipore SD-2 was added to the BDS experiments at resin concentrations of 22 
0, 10 or 50 g-resin/L-total.  The HBP concentration within the cytoplasm was estimated to 23 
decrease from 1100 to 260 μM with increasing resin concentration.  Despite this finding, 24 
productivity did not increase with resin concentration.  This led us to focus on the susceptibility 25 
of the desulfurization enzymes towards HBP.  Dose-response experiments were performed to 26 
identify major inhibitory interactions in the most common BDS pathway, the 4S pathway.  HBP 27 
was responsible for three of the four major inhibitory interactions identified.  The concentrations 28 
of HBP that led to 50% reduction in the enzymes’ activities (IC50) for DszA, DszB and DszC 29 
were measured to be 60 ± 5 μM, 110 ± 10 μM and 50 ± 5 μM, respectively.  The fact that the 30 
IC50 values for HBP are all significantly smaller than the cytoplasmic HBP concentration 31 
suggests that the inhibition of the desulfurization enzymes by HBP is responsible for the 32 
observed reduction in biocatalyst activity concomitant with HBP generation. 33 
Keywords: Enzyme inhibition, Rhodococcus erythropolis IGTS8, biodesulfurization, 34 
dibenzothiophene, 2-hydroxybiphenyl35 
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Introduction 36 
Biodesulfurization (BDS) is a process in which microorganisms, typically bacteria, are used to 37 
reduce the level of sulfur in fuels derived from crude oil including diesel and gasoline.  BDS has 38 
gained interest over the last 20 years as an alternative to hydrodesulfurization (HDS), which is 39 
the current desulfurization standard in the oil industry.  HDS uses a metal catalyst along with 40 
hydrogen gas (H2) at high temperature and pressure to remove sulfur from organic sulfur 41 
compounds and generate H2S gas  (1).  Major drawbacks of HDS include steric hindrance of the 42 
metal catalysts by certain recalcitrant compounds and large energy consumption due to process 43 
operation at high temperature and pressure (1).  Recalcitrant compounds include the parent 44 
molecule dibenzothiophene (DBT) and some of its alkylated derivatives, such as 4-45 
methyldibenzothiophene (4-DBT) and 4,6-dimethyldibenzothiophene (4,6-DBT).  BDS can 46 
potentially be used to remove the sulfur that cannot be removed by HDS, though it is likely not a 47 
replacement for the current HDS infrastructure.  The use of more than one desulfurization 48 
technology may be necessary to meet the increasingly stringent sulfur regulations (1). 49 
There is a wide range of microorganisms known to have BDS capability (2).  Such 50 
microorganisms typically desulfurize DBT by one of two pathways: the Kodama pathway or the 51 
4S pathway (1).  The Kodama pathway is a destructive BDS pathway in which carbon-carbon 52 
bonds in the DBT molecule are broken and sulfur is not selectively removed from the organic 53 
molecule.  Due to its destructive nature, the Kodama pathway reduces the caloric value of the 54 
fuel that is being desulfurized.  As a result, the majority of the focus on the past 20 years has 55 
been on the 4S pathway, which is an oxidative desulfurization pathway that cleaves the carbon-56 
sulfur bond in DBT and leaves the carbon structure intact.  The 4S pathway is a four-step 57 
enzymatic pathway that converts DBT to 2-hydroxybiphenyl (HBP) and sulfate (Figure 1).  The 58 
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first two steps are the conversion of DBT to DBT-sulfoxide (DBTO) and then to DBT-sulfone 59 
(DBTO2).  These steps are catalyzed by the enzymes DszC monooxygenase and DszD 60 
oxidoreductase in synchrony. The third step is the conversion of DBTO2 to 2-(2′-hydroxyphenyl) 61 
benzene sulfinate (HBPS), which is catalyzed by DszA monooxygenase and DszD 62 
oxidoreductase in synchrony.  The final step is the conversion of HBPS to HBP and sulfite by 63 
DszB desulfinase (3).  64 
The isolation and purification of the desulfurization enzymes from R. erythropolis IGTS8 65 
has been reported (4, 5).  Preliminary characterization of these enzymes showed that DszB 66 
catalyzes the slowest reaction with a turnover number (kcat) of “about 2 min-1” (4).  Furthermore, 67 
it was reported that DszA “has a turnover number (kcat) of about 1/sec” (4).  Following the 68 
finding that DszB catalyzes the slowest step, the kinetics of DszB was investigated in detail (6).  69 
DszB kinetics was modeled appropriately by the Michaelis-Menten model with a Michaelis 70 
constant (Km) of 0.90 ± 0.15 μM and a kcat of 1.3 ± 0.07 min-1 (6).  The kinetics of DszA, DszC, 71 
and DszD from R. erythropolis IGTS8 have yet to be investigated in detail.  72 
Two major obstacles facing BDS commercialization are that: (1) biocatalyst activities are 73 
significantly lower than what is needed for BDS rates to match HDS rates (2); and (2) 74 
biocatalysts cannot maintain activity for a long period of time.  Considerable effort has gone into 75 
trying to understand and overcome the limitations to the desulfurization activity of the 76 
biocatalysts.  Several studies have shown that genetic engineering can lead to higher 77 
desulfurization activities (2).  For example, the desulfurization activity of R. erythropolis KA2-5-78 
1 was increased from 50 to 250 μmol DBT/g DCW/h by providing multiple copies of the 79 
desulfurization genes and placing them under the control of alternative promoters (2).   80 
Reduction in biocatalyst activity over time has been widely reported in BDS processes (2, 81 
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7,  8).  The reduction in activity is typically correlated to the accumulation of HBP in the 82 
medium during the BDS process.  The desulfurization activity of a cell suspension of R. 83 
erythropolis IGTS8 of cell density 66 g DCW/L mixed with hexadecane (at 1:1 v/v ratio) 84 
containing 19000 μM DBT was found to follow first order decay with decay constant of 0.072 h-85 
1 (7).  It was suggested that the loss of biocatalyst activity might be due to exposure to increasing 86 
HBP concentrations, although no experiments were done to validate this hypothesis (7).  The 87 
cells were active for 24 hours and only 7000 out of 19000 μM DBT in oil was consumed.  The 88 
final concentration of HBP accumulated in the oil phase after 24 hours was only 3300 μM.  89 
Although aqueous phase accumulation of DBT or HBP was not measured, the contribution from 90 
the aqueous phase concentration to the overall concentration of either compound could not have 91 
been more than 5%.  This was estimated based on the partition coefficients of DBT and HBP 92 
between hexadecane and water (PO/W), which are 21000 and around 30-50, respectively (9).  As a 93 
result, approximately 3600-3700 μM of DBT or HBP are unaccounted for at the end of the BDS 94 
process.  Possible reasons for the discrepancy between DBT disappearance and HBP 95 
accumulation are accumulation of pathway intermediates or retention of DBT and/or HBP within 96 
the biocatalyst.  R. erythropolis, being a gram-positive bacteria, has a cytoplasmic membrane 97 
surrounded by a thick cell wall made mostly of peptidoglycan.  The cell wall is composed of 98 
thick peptidoglycan structure to which fatty acid molecules are attached.  In the case of R. 99 
erythropolis (a member of the actinomycetes family), the cell wall is composed of mycolic acids 100 
that are perpendicular to the cell surface (10).  These mycolic acids range from 30 to 54 carbon 101 
atoms in length and they make the cell wall of R. erythropolis highly hydrophobic.  It is possible 102 
that a significant concentration of DBT initially in the oil phase would have been retained within 103 
the cell wall of R. erythropolis IGTS8 as it entered the cell.  It is also possible that a significant 104 
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fraction of HBP produced by the biocatalyst would have been trapped within the biocatalyst 105 
cytoplasmic membrane or cell wall as it exited the cell.  The amount of DBT or HBP retained by 106 
the biocatalyst will depend on the partition coefficients between the biocatalyst and the oil or 107 
aqueous phases, PC/O or PC/W, respectively. 108 
A number of studies have investigated the effect of HBP on biocatalyst activity.  HBP has 109 
been shown to inhibit the growth of R. erythropolis IGTS8 at concentrations greater than 200 μM 110 
(11).  Preliminary characterization of the DszB enzyme from R.erythropolis KA2-5-1 showed 111 
that its activity is reduced by 50% at HBP concentrations around 2000 μM (12).  In other studies, 112 
the effect of exogenously added HBP on the BDS process has been described.  R. erythropolis 113 
IGTS8 aqueous resting cell suspensions of 2 g DCW/L were prepared and supplied with only 114 
one of the 4S pathway compounds (either DBT, DBTO, DBTO2 or HBPS) (13).  HBP was also 115 
added at concentrations of either 0 and 50 μM in each experiment.  The disappearance rate of 116 
each compound was monitored over a short period of 15 min.  It was found that the 117 
disappearance rates of DBTO and HBPS were significantly reduced by the presence of 50 μM 118 
HBP.  These results suggested that HBP might be inhibitory to the enzymes responsible for 119 
DBTO and HBPS consumption, which are DszC and DszB, respectively (Figure 1).  In a 120 
different study, the DBT desulfurization rate of resting cells of Microbacterium sp. ZD-M2 was 121 
found to decrease significantly when HBP was added exogenously at concentrations ranging 122 
from 0-2000 μM (14).  Results from experiments where HBP is added exogenously cannot be 123 
used to quantitatively predict the effect of HBP on a typical BDS process where DBT is added 124 
exogenously and HBP is generated endogenously within the cytoplasm of the cells.  When HBP 125 
is added exogenously, a significant fraction may be retained by the cell wall and may never reach 126 
the cytoplasm, where inhibition of the desulfurization enzymes could occur.  On the other hand, 127 
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HBP generated endogenously within the cytoplasm is immediately at the location where it can be 128 
inhibitory to the desulfurization enzymes.  Therefore, the specific HBP loading of the biocatalyst 129 
(mg HBP/g DCW) that leads to a certain level of reduction in BDS activity may be significantly 130 
larger when HBP is added exogenously. 131 
In summary, there is sufficient evidence to suggest that HBP (either generated 132 
endogenously or supplied exogenously) reduces the overall biocatalyst activity.  In this work, a 133 
series of commercially available adsorbents were screened for their affinity and selectivity to 134 
adsorb HBP.  The best adsorbent was used to determine whether or not HBP selective adsorbents 135 
could help mitigate the loss of desulfurization activity correlated with HBP accumulation during 136 
the BDS process.  The kinetics and inhibition of the four enzymes in the 4S pathway by the 137 
intermediate compounds were next investigated in detail, in an attempt to understand the 138 
mechanism for the reduction in biocatalyst activity that is correlated with HBP accumulation. 139 
 140 
Materials and Methods 141 
Bacterial strains, vectors, media and chemicals.  The DBT-desulfurizing strain used in this study 142 
was Rhodococcus erythropolis IGTS8 ATCC® 53968TM, purchased from the American Type 143 
Culture Collection (USA).  The defined minimal medium (MM) for cultivation contained (per 144 
liter of deionized water): glucose 30.0 g, NH4Cl 3.0 g, K2HPO4.3H2O 6.75 g, NaH2PO4.H2O 2.25 145 
g, MgCl2 0.245 g, FeCl3 4 mg, CaCl2 4 mg, Na2SO4 0.14 g, ZnCl2 32 mg, MnCl2.4H2O 1 mg, 146 
CuCl2.2H2O 5 mg, Co(NO3)2.6H2O 0.7 mg, Na2B4O7.10H2O 0.7 mg, (NH4)6Mo7O24.4H2O 1 mg, 147 
EDTA 12 mg.  Cryogenic stocks were prepared by addition of 15% (vol./vol.) glycerol (final 148 
concentration) to mid-log growth phase cultures in MM, which were then kept at -80°C for long 149 
term storage.  Medium components were obtained from VWR International (USA).  Dr. 150 
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Christine Nguyen, from Professor Stephen Buchwald’s research group at MIT, kindly provided 151 
HBPS.  All other chemicals were obtained from Sigma-Aldrich (USA).  The strains used for 152 
expression of the desulfurization genes were Escherichia coli MAX Efficiency® DH10BTM and 153 
E. coli BL21 StarTM (DE3) One Shot® from InvitrogenTM.  The vector used for all molecular 154 
manipulations was pETDuet-1 from Novagen®.  The medium used to culture these strains was 155 
Luria-Bertani (LB) broth from DIFCO® supplemented with ampicillin (100 μg/ml working 156 
concentration) for selection of clones containing the pETDuet-1 vector. 157 
  158 
Testing HBP adsorbents. Activated charcoal, molecular sieves (of 4, 5, and 13 Å pores), 159 
Diaion® HP-20, Dowex® Optipore L-493, SD-2, Biobeads, Amberlite® XAD4, IRC86, IRA958 160 
were all obtained from Sigma-Aldrich (USA).  Resins were tested for their ability to adsorb HBP 161 
from a hexadecane-water solution.  The adsorption experiments were carried out in 20 mL 162 
scintillation vials by mixing 5 mL of water with 5 mL of a hexadecane solution containing 10000 163 
μM DBT and 10000 μM HBP with either 0.1 or 1.0 g of resin. Mixtures were equilibrated for 24 164 
h at 30oC, with agitation at 250 rpm.  After measuring solute concentrations before and after 165 
sample equilibration with a particular resin concentration (Xr), specific loadings (Lr) were 166 
determined by the following relationships: 167 
Xr =
mr
Vtotal
           
(1)
 
168 
Lr =
CHBP t0 − CHBP teq
 
  
 
  MWHBP
Xr
,        (2) 169 
where CHBP represents the total concentration of HBP (in oil and water), Vtotal is the total volume 170 
of solution (oil plus water), mr is the mass of resin used, Xr is the concentration of resin 171 
 9
employed, MWHBP is the molecular weight of HBP (170 g/mole), and t0 and teq represent time at 172 
initial and equilibrium conditions, respectively. 173 
 174 
Resting cells preparation.  R. erythropolis IGTS8 cultures were grown in 400 mL of MM in a 2L 175 
shake flask for a period of 40-48 hours during which the cell density increased from 176 
approximately 0.03 g DCW/L to 3 g DCW/L.  Cultures were centrifuged at 5000 RPM and 4°C 177 
for 15 min and spent media was discarded.  Biocatalyst pellets were resuspended to the 178 
experimental cell density in 5 g/L glucose and 20 mM phosphate buffer pH 7.0.  179 
 180 
Four-component biodesulfurization experiments.  BDS experiments in the presence of Dowex® 181 
Optipore SD-2 resin were carried out in 250 mL shake flasks containing 20 mL of a 15.5 g 182 
DCW/L resting cell suspension mixed with 20 mL of hexadecane containing 10000 μM DBT.  183 
The resin was added to the mixture at resin concentrations of Xr = 0, 10 or 50 g/L in the shake 184 
flask and the flasks were incubated at 30°C for 26 hours.  After the 26-hour incubation period, 185 
the mixtures were centrifuged for 15 min at 5000 RPM and the four components (oil, water, cells 186 
and resin) were separated.  DBT and HBP concentrations in the oil and aqueous components 187 
were measured directly after centrifugation.  DBT and HBP concentrations in the cells and resin 188 
were measured by extraction into ethanol.  Ethanol was selected as the best extractant among a 189 
variety of solvents tested, including acetone, methanol, hexane, hexadecane, squalane, and 190 
toluene.  Cell wall solubilization by treatment with an enzymatic mixture of lysozyme (100 191 
mg/mL) and mutanolysin (5000 Units/mL) did not increase the concentration of DBT or HBP 192 
extracted from the cells.  Sonication of the cells also did not increase extraction concentrations. 193 
Loadings of HBP on the biocatalyst (Lc) and resin (Lr) were calculated from the expressions: 194 
 10
Lc =
Cextract,i
i
   
 
  Vextract
mcells          
(3)
 
195 
Lr =
Cextract,i
i
   
 
  Vextract
mresin ,         
(4) 196 
where Cextract,i is the concentration of HBP in the ith extract, Vextract is the volume of the extract 197 
(constant for each fraction), mcells is the mass of cells extracted, and mresin is the mass of resin 198 
extracted. 199 
 200 
DNA manipulations and preparation of E. coli recombinant strains.  Molecular biology 201 
manipulations were performed according to standard protocols.  Genomic DNA was extracted 202 
from R. erythropolis IGTS8 using Promega’s Wizard® genomic DNA purification kit.  Each of 203 
the desulfurization genes was PCR-amplified from the extracted genomic DNA with appropriate 204 
primers (see Supplemental Material).  Restriction sites for EcoRI and HindIII were included in 205 
the primers.  PCR amplicons were then cut with the appropriate restriction enzymes and ligated 206 
with the pET-Duet vector that had been previously cut with the corresponding restriction 207 
enzymes.  The resulting vectors containing the four genes (dszA, dszB, dszC and dszD) were 208 
sequence-verified.  Each of the 4 vectors was then used to transform E. coli DH10B by 209 
electroporation using 1 mm pathlength cuvettes.  E. coli BL21 StarTM (DE3) One Shot® was 210 
used as the expression host for each of the four desulfurization proteins, and transformed 211 
according to the manufacturer’s protocol (Invitrogen). Ampicillin selection (100 μg/mL) was 212 
used to identify successful transformants.  213 
 214 
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Protein expression and purification protocol.  The following protocol was followed to express 215 
and purify each of the four desulfurization enzymes: 216 
1. A transformed E. coli BL21 colony from an LB-ampicillin plate was picked and grown in 217 
10 mL LB with ampicillin at 30°C overnight. 218 
2. The next day, 1 L of LB medium with ampicillin was inoculated with 10 mL of overnight 219 
culture and grown at 30°C with shaking at 250 RPM.  220 
3. The 1L culture was induced with 0.3 mM IPTG when the OD600 of the culture was 0.5-0.6. 221 
Growth was continued for 18 hours at 20°C.   222 
4. Cells were harvested by centrifugation at 5000 RPM for 15 minutes at 4°C. 223 
5. The supernatant was discarded and the cell pellet was frozen at -20°C overnight. 224 
6. From this point on all cells and protein samples were maintained at 4°C or on ice to avoid 225 
protein degradation.  The cell pellet was resuspended using a volume of the 1X His buffer 226 
(with 10% glycerol) equal to at least 2.5 times the mass of the cell pellet. Lysozyme (1 227 
mg/mL) and DNAseI (500 μg/mL) were added and the cell suspension was incubated for 228 
30 minutes on ice. 229 
7. The cell suspension was sonicated for 15-30 minutes at 90-100% amplitude with 1-second 230 
on/1-second off cycle.  231 
8. Cell debris was pelleted by centrifugation at 20,000 rpm for 30 minutes at 4°C.   232 
9. The supernatant (20-40 mL) was mixed with 5 mL Ni-NTA agarose (Qiagen) in order to 233 
bind the histidine-tagged desulfurization protein to the resin.  The time for this binding step 234 
was 1 hour at 4°C.  235 
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10. After the 1 hour binding step, the protein-resin mixture was poured onto a Pierce® 236 
centrifuge column (10 mL total volume) and the resin was allowed to settle.  The flow-237 
through was processed by gravity flow and collected. 238 
11. The resin was washed with 10 mL of 1X His buffer containing 7.5 mM imidazole and the 239 
flow through was collected.  Then, the resin was treated with five different solutions of 1X 240 
His buffer containing increasing imidazole concentrations of: 40, 60, 100, 250 and 500 mM 241 
imidazole.  Each solution was 5 mL in volume.  The eluent of each fraction was collected. 242 
12. A diagnostic SDS-PAGE gel was run to determine the fractions with the highest purity. 243 
These fractions were combined in one piece of snakeskin dialysis tubing and the protein 244 
sample was dialyzed overnight in 1L of 50 mM Tris-HCl/50 mM NaCl/10% glycerol 245 
buffer in the cold room with mild stirring. 246 
13. Finally, the dialyzed protein was flash-frozen using liquid nitrogen in small aliquots for 247 
long-term storage at -80°C.   248 
 249 
Enzyme assays.   250 
All enzyme assays were performed in 20 mM phosphate buffer at pH 7.0 and 30°C.  The assay 251 
volume was 1000 μL for all assays.  DszD assays were performed in semi-micro cuvettes and 252 
maintained at room temperature.  DszA, DszB and DszC assays were performed in 1.7 mL 253 
Eppendorf tubes in a rotary shaker incubator at 30°C and 250 RPM and were quenched either by 254 
addition of 1% of a 12 M HCl solution or by using an Amicon Ultra-0.5 mL 10 kDa spin filter 255 
device to remove the enzyme. For DszD enzyme assays, either the concentration of NADH was 256 
varied from 0-400 μM (at fixed FMN = 100 μM) or the concentration of FMN was varied from 257 
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0-100 μM (at fixed NADH = 150 μM), the concentration of DszD enzyme was 1.2 μg/mL, and 258 
the assays were run for 10 minutes.  For DszC enzyme assays, the concentration of NADH was 259 
500 μM, FMN concentration was 10 μM, DBT concentration was varied from 0-5 μM, DszD 260 
concentration was 0.47 μg/mL, DszC concentration was 3.1 μg/mL and the assays were run for 5 261 
minutes.  Assay conditions were identical for determining the mechanism of DszC inhibition by 262 
HBPS and HBP except for the addition of those compounds at concentrations of 0-200 and 0-263 
1000 μM, respectively.  For DszA enzyme assays, the NADH concentration was 500 μM, FMN 264 
concentration was 10 μM, DBTO2 was varied from 0-80 μM, DszD concentration was 1.4 265 
μg/mL, DszA concentration was 6.7 μg/mL, and the assays were run for 3 min.  For DszB 266 
enzyme assays, the HBPS concentration was varied from 0-200 μM, DszB concentration was 3.5 267 
μg/mL, and the assays were run for 5 min.  For all four enzymes dose-response type assays were 268 
performed to measure the inhibitory concentration leading to 50% reduction in enzyme activity 269 
(IC50). For DszD dose-response assays, the concentration of NADH was 500 μM and that of 270 
FMN was 200 μM, the concentration of the various pathway intermediates was varied (DBT: 0-5 271 
μM, DBTO2: 0-80 μM, HBPS: 0-2000 μM, HBP: 0-2000 μM), the concentration of DszD was 272 
4.7 μg/mL, and the assays were run for up to 5 minutes. For DszC dose-response assays, NADH 273 
concentration was 500 μM, FMN concentration was 10 μM, DBT concentration was 5 μM, DszD 274 
concentration was 0.47 μg/mL, DszC concentration was 0.3 mg/mL, the concentration of the 275 
pathway intermediates was varied (DBTO2: 0-80 μM, HBPS: 0-1000 μM, HBP: 0-2000 μM), 276 
and the assays were run for 10 min.  For DszA dose-response assays, the NADH concentration 277 
was 500 μM, FMN concentration was 10 μM, DBTO2 concentration was 80 μM, DszD 278 
concentration was 1.4 μg/mL, DszA concentration was 67 μg/mL, the concentration of the 279 
pathway intermediates was varied (DBT: 0-5 μM, HBPS: 0-500 uM, HBP: 0-1000 μM), and the 280 
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run time was 3 min. For DszB dose-response assays, HBPS concentration was 200 μM, the DszB 281 
concentration was 58.5 μg/mL, the concentration of the pathway intermediates was varied (DBT: 282 
0-5 μM, DBTO2: 0-80 μM, HBP: 0-1000 μM), and the assays were run for 5 min. 283 
   284 
Analytical methods.  For DszD assays, the absorbance at 340 nm was measured using a 285 
spectrophotometer to calculate the NADH concentration and this was used to calculate the 286 
activity.  The concentrations of DBT, DBTO2, HBPS and HBP were measured using reversed 287 
phase HPLC with a Zorbax SB-C18 column at a flow rate of 1 mL/min.  For DszC and DszB 288 
assays, the mobile phase was 50% acetonitrile-50% water and the temperature of the column was 289 
maintained at 65°C.  For DszA assays, the mobile phase was 30% acetonitrile-70% 10 mM 290 
tetrabutylammonium bisulfate, 15 mM acetic acid pH 5.0 mobile phase and the temperature of 291 
the column was maintained at 45°C.  292 
 293 
Results 294 
Screening HBP-selective adsorbent resins. A variety of commercially available resins were 295 
screened for their ability to uptake HBP and DBT from a 0.50 vol/vol hexadecane-water solution 296 
with an initial concentration of 10000 μM DBT and 10000 μM HBP in hexadecane.  The resins 297 
screened in this study were chosen because they span a wide range of resin hydrophobicity and 298 
ionic functionalities, and most have been previously investigated in our lab (15).  We found that 299 
poly(styrene-co-DVB) derived resins generally have the greatest affinity for HBP (Figure 2A, Xr 300 
= 10 g-resin/L-total for each resin).  For instance, Dowex® Optipore L-493 and SD-2 were able 301 
to achieve specific loadings of HBP of 40 and 50 mg/g-resin, respectively.  In addition to having 302 
the highest affinity for HBP of all the resins tested, Dowex® Optipore L-493 and SD-2 also 303 
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possessed the highest selectivity for HBP relative to DBT with HBP loadings that were 2.1 and 304 
2.5 times greater than their respective DBT loadings.  These resins were also found to have the 305 
highest affinity for butanol, with specific loadings of butanol of 175 and 150 mg/g-resin, 306 
respectively (15).  The high affinity of these resins for butanol has been attributed to strong 307 
hydrophobic interactions between the resin’s π-π bonds of the aromatic side groups and the alkyl 308 
chain of butanol and to the resin’s high specific surface area (15).  The affinity of these resins for 309 
HBP is likely due to strong hydrophobic interactions between the resin’s aromatic side groups 310 
and the biphenyl part of HBP, though the specific loadings are reduced relative to n-butanol.  311 
 312 
Four-component BDS experiments.  We previously reported that the DBT desulfurization 313 
activity of R. erythropolis IGTS8 was significantly reduced as HBP accumulated in the medium 314 
during the BDS process (A. Abin-Fuentes, J.C. Leung, M.E.S Mohamed, D.I.C Wang, K.L.J. 315 
Prather, submitted for publication).  In particular, we found that the activity of a resting cell 316 
suspension of 15.5 g DCW/L was decreased by 90% when the HBP concentration in the aqueous 317 
medium reached 40 μM (A. Abin-Fuentes, J.C. Leung, M.E.S Mohamed, D.I.C Wang, K.L.J. 318 
Prather, submitted for publication).  In previous work, the use of Dowex® Optipore SD-2 in 319 
butanol fermentations led to a decrease in aqueous phase concentration and increase in 320 
productivity (15). In the current work, this resin, which had the best affinity and selectivity for 321 
HBP of all resins studied, was used to try to mitigate the reduction in biocatalyst activity 322 
correlated with HBP accumulation during the BDS process, thereby increasing the conversion of 323 
DBT.  R. erythropolis IGTS8 resting cell suspensions of 15.5 g DCW/L were mixed with 324 
hexadecane (0.50 vol/vol) containing 10000 μM DBT and Dowex® Optipore SD-2 was added at 325 
Xr of 0, 10 or 50 g/L.  The four-component (oil, water, cells and resin) mixtures were incubated 326 
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at 30°C in a rotary shaker at 250 RPM for 26 hours.  The concentration of DBT and HBP in each 327 
component was measured at the end of the incubation period. The partition coefficient of HBP 328 
between one component (component 1) and another component (component 2) in the four-329 
component BDS experiments is expressed as:  330 
 Pcomp1/ comp2 =
CHBP,comp1
CHBP,comp2 ,         
(5)
 
331 
where CHBP,comp1 is the measured HBP concentration in component 1 and CHBP,comp2 is the 332 
measured HBP concentration in component 2.  For example, PR/C is the partition coefficient of 333 
HBP between the resin and the biocatalyst (cells).  Similarly, PO/W is the partition coefficient of 334 
HBP between hexadecane (oil) and water.  The partition coefficients calculated at the different 335 
resin concentrations are shown in Table I.  The resin Dowex Optipore® SD-2 had the highest 336 
affinity for HBP relative to the other components of the system.  This resin had log PR/C and log 337 
PR/O values around 2, which means that the resin’s affinity for HBP was around 100 times greater 338 
than the affinity of either the hexadecane oil phase or the biocatalyst.  Furthermore, this resin had 339 
a log PR/W around 4, which means that its affinity for HBP was around 10,000 times greater than 340 
that of the aqueous buffer.  The partition coefficients of HBP between oil and the aqueous buffer 341 
(PO/W) and between the biocatalyst and the aqueous buffer (PC/W) were very similar (Table I).  342 
The log PO/W and log PC/W in the absence of resin were 1.7 and 1.8, respectively.  Also, the 343 
partition coefficient of HBP between the biocatalyst and oil (PC/O) was calculated to be 1 in the 344 
absence of resin.  The finding that PO/W ≈ PC/W and PC/O ≈ 1 indicates that the oil and biocatalyst 345 
components have very similar affinity for HBP.  Both the oil and the biocatalyst have an affinity 346 
for HBP that is 50-60 times greater than that of the aqueous buffer in the absence of resin (Table 347 
I). 348 
The partition coefficient PC/W is defined as: 349 
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PC /W =
CHBP, intracellular
CHBP, water ,          
(6) 350 
 where CHBP,water is the HBP concentration in the water phase and CHBP,intracellular is the HBP 351 
concentration within the biocatalyst.  The cell can be viewed as being composed of two 352 
components: the inner cytoplasmic space and the outer envelope/shell that encompasses the 353 
cytoplasm, which is the cell wall. The partition coefficient of HBP between the cytoplasm and 354 
water (Pcytoplasm/W) was estimated from solving for its value in the expression: 355 
PC /W = Pcell wall/W fcell wall + Pcytoplasm/W fcytoplasm        (7) 356 
where Pcell wall/W  is the partition coefficient of HBP between the cell wall and the water.  The 357 
value of Pcell wall/W was estimated to be 550 (see Supplemental Material).  fcell wall and fcytoplasm are 358 
the fractions of the total volume of a single cell that are occupied by the cell wall and cytoplasm, 359 
respectively.  The values of fcytoplasm and fcell wall were calculated from the expressions: 360 
fcytoplasm =
Rcell −W( )3
Rcell( )3          
(8) 361 
   362 
      363 
fcell wall =1−
Rcell −W( )3
Rcell( )3 ,         
(9) 364 
        365 
 366 
where W is the thickness of the cell wall, which has been estimated to be approximately 10 nm 367 
for Rhodococcous species (16).  Rcell is the radius of the cell, which was estimated to be 0.5 μm 368 
(17).  The cytoplasmic HBP concentration (CHBP,cytoplasm) was calculated from the following 369 
expression: 370 
CHBP, cytoplasm = Pcytoplasm/W CHBP,water          (10) 371 
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The value of CHBP,cytoplasm was calculated to be 1100, 330 and 260 μM at resin concentrations (Xr) 372 
of 0, 10 and 50 g/L, respectively (Figure 2B).  The corresponding HBP loadings on the 373 
biocatalyst (Lc) were calculated to be 1.6, 0.5 and 0.2 mg HBP/g DCW using equation 3 (Figure 374 
2B).  These values show that the resin was effective in reducing HBP retention within the 375 
cytoplasm of the biocatalyst, which is where the desulfurization enzymes are present (4).  376 
Despite the significant decrease in HBP retained within the cytoplasm, the total amount of HBP 377 
produced in the system did not increase with increasing resin concentration (Figure 2B). 378 
Therefore, it was postulated that the biocatalyst, and in particular the desulfurization enzymes, 379 
might be susceptible to cytoplasmic HBP concentrations smaller than 260 μM.  380 
 381 
Enzyme kinetics. To study the kinetics of each enzyme, recombinant protein was expressed in 382 
and purified from E. coli (See Supplemental Material).  For DszA, DszB and DszD, the kinetic 383 
data obtained was appropriately modeled by the Michaelis-Menten model (Figure 3A, 3B, 3D).  384 
The equation for this model is:  385 
ν =
kcat[E0][S]
Km + [S]
=
Vmax[S]
Km + [S] ,         
(11)
 
386 
where ν is the enzyme activity, kcat is the turnover number, [E0] is the enzyme concentration in 387 
each assay, [S] is the substrate concentration and Km is the Michaelis constant. The kinetics of 388 
DszC could not be modeled accurately with a simple Michaelis-Menten model because it was 389 
found that DszC was inhibited by its substrate DBT (Figure 3C).  As a result, a substrate 390 
inhibition model was used to fit the data obtained with DszC (18): 391 
v = Vmax[S]
Km + [S] +
[S]2
KSI ,          
(12) 392 
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where KSI is the substrate (DBT) inhibition constant.   393 
The fitting of the models to the data was done using the enzkin package in MATLAB®.  The 394 
kinetic data obtained for all four desulfurization enzymes is shown in Figure 3.  The kinetic 395 
parameters of each enzyme are summarized in Table II and compared to parameters from other 396 
studies, where available.  To our knowledge, the only prior detailed characterization of a 397 
desulfurization enzyme from R. erythropolis IGTS8 found kcat = 1.3 ± 0.07 min-1 and Km = 0.90 398 
± 0.15 μM for DszB (6).  In the current work, kinetic characterization of DszB yielded kcat = 1.7 399 
± 0.2 min-1 and Km = 1.3 ± 0.3 μM, which are in good agreement with values from the previous 400 
study.  Rough preliminary characterization of DszA and DszD from R. erythropolis IGTS8 401 
yielded kcat values of “about 60 min-1” and approximately 300 min-1, respectively (4).  The 402 
corresponding values of kcat for DszA and DszD measured in this work were 11 ± 2 min-1 and 403 
760 ± 10 min-1, which are of the same order of magnitude as those rough estimates from 404 
preliminary characterization studies.  DszC was inhibited by its substrate DBT and the kinetic 405 
parameters obtained were kcat = 1.6 ± 0.3 min-1, Km = 1.4 ± 0.3 μM and KSI = 1.8 ± 0.2 μM.  The 406 
activity of DszC from R. erythropolis D-1 was reported as 30.3 nmole DBTO2/mg DszC/min 407 
(19), which is in close agreement with the maximum activity measured in this work of 31.3 408 
nmole DBTO2/mg DszC/min (Figure 3C). 409 
 The catalytic efficiency of an enzyme is best defined by the ratio of the kinetic constants, 410 
kcat/Km (20).  The catalytic efficiency of each desulfurization enzyme was calculated (Table II).  411 
The catalytic efficiencies of DszA, DszB, DszC were calculated to be 3.1, 1.3, 1.1 μM-1min-1, 412 
respectively.  The catalytic efficiency of DszD on NADH and FMN was calculated to be 6.7 and 413 
100 μM-1min-1, respectively.  Therefore, the enzymes can be listed in order of decreasing 414 
efficiency as: DszD > DszA > DszB ≈ DszC.   415 
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 416 
Identification of four major inhibitory interactions in the 4S pathway.  All of the possible 417 
interactions among the 4 different desulfurization enzymes and the four compounds in the 418 
pathway (DBT, DBTO2, HBPS and HBP) were studied to determine the major inhibitory 419 
interactions.  DBTO was not included because it is not typically observed during the BDS 420 
process because its rate of consumption is much faster than its rate of generation (4).  The 421 
strength of inhibition was studied by means of a dose-response plot.  The dose-response equation 422 
describing the effect of inhibitor concentration on enzyme activity is expressed as (20): 423 
ν i
ν0
=
1
1+
I[ ]
IC50 ,           
(13) 424 
where νi is the enzyme’s activity at an inhibitor concentration of [I], ν0 is the enzyme’s activity in 425 
the absence of inhibitor, and IC50 is the concentration of inhibitor required to reduce the 426 
enzyme’s activity by 50%.  The IC50 parameter is phenomenological and has no mechanistic 427 
implications.  The value of IC50 was obtained by fitting the data of νi /ν0 versus [I] using the non-428 
linear fitting package nlinfit in MATLAB® to the dose-response equation.  The four major 429 
inhibitory interactions identified were (in order of decreasing strength): DszC inhibition by 430 
HBPS (IC50 = 15 ± 2 μM), DszC inhibition by HBP (IC50 = 50 ± 5 μM), DszA inhibition by HBP 431 
(IC50 = 60 ± 5 μM) and DszB inhibition by HBP (IC50 = 110 ± 10 μM) (Figure 4 and Table III).  432 
Note that the IC50 values of all four inhibitory interactions are significantly smaller than the 433 
estimated cytoplasmic HBP concentration.  Even in the best-case scenario, when 50 g/L of a 434 
highly HBP-selective resin was added to the BDS mixture, the estimated cytoplasmic HBP 435 
concentration was still 260 μM.  This finding suggests that these four inhibitory interactions are 436 
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likely responsible for the reduction in biocatalyst activity that is observed during a typical BDS 437 
process when HBP is generated endogenously from DBT within the biocatalyst.   438 
The only prior preliminary characterization of inhibition within the 4S pathway showed 439 
that DszB from R. erythropolis KA2-5-1 had an IC50 of around 2000 μM with respect to HBP 440 
(12).  We report here three new inhibitory interactions in the pathway that are stronger than any 441 
previous preliminary findings.  Note that the strongest inhibitory interactions are on the first 442 
enzyme in the pathway, DszC, and the strength of inhibition decreases farther down the pathway, 443 
with the last enzyme in the pathway, DszB, having the weakest HBP inhibition at IC50 = 110 μM 444 
(Figure 4B).  Note also that the major inhibitory compounds in the pathway are the last two 445 
intermediates, HBPS and HBP.  This pattern of inhibition is typical of feedback inhibition of 446 
linear pathways; for example, in the tricarboxylic acid (TCA) cycle the first enzyme in the 447 
pathway is strongly inhibited by the end product ATP. 448 
Mechanism of the major inhibitory interactions in the 4S pathway.  The telltale sign of non-449 
competitive inhibition is a reduced Vmax without a change in Km as the inhibitor concentration is 450 
increased (20).  This phenomenon was observed in the inhibition of DszC by both HBPS and 451 
HBP (Figure 5A and Figure 5B).  The model for non-competitive inhibition of an enzyme that 452 
obeys Michaelis-Menten kinetics is given by (20): 453 
ν =
Vmax[S]
Km 1+
[I]
KI
 
  
 
  + [S] 1+
[I]
αKI
 
  
 
  ,        
(14) 454 
where [I] is the inhbitior concentration, Ki is the inhibition constant, and α is a parameter that 455 
reflects the effect of inhibitor on the affinity of the enzyme for its substrate, and likewise the 456 
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effect of the substrate on the affinity of the enzyme for the inhibitor.  Non-competitive inhibition 457 
refers to the case in which an inhibitor displays binding affinity for both the free enzyme and the 458 
enzyme-substrate binary complex (see Supplemental Material).  This form of inhibition is the 459 
most general case; in fact, competitive and uncompetitive inhibition can be viewed as special, 460 
restricted cases of non-competitive inhibition in which the value of α is infinity or zero, 461 
respectively (20).  Since the kinetics of DszC showed substrate inhibition, a modification to the 462 
non-competitive model was derived (see Supplemental Material).  The non-competitive 463 
inhibition of DszC by HBPS and HBP can be expressed as: 464 
ν =
Vmax[S]
Km 1+
[I]
KI
 
  
 
  + [S] 1+
[I]
αKI
 
  
 
  +
[S]2
KSI
       (15) 465 
The solid lines in Figures 5A and 5B represent the fits for the non-competitive inhibition model 466 
(equation 15), where the values of Ki and α were 13.5 μM and 0.13 for HBPS inhibition and 40 467 
μM and 0.4 for HBP.  Fitting of the model to the data was attempted using nlinfit from 468 
MATLAB®, but was unsuccessful due to convergence issues.  Instead the parameters were 469 
determined by a graphical method outlined in section 8.3 of (20).  The first step in this method 470 
was the construction of the double-reciprocal Lineweaver-Burk plot.  To obain the values of Ki 471 
and αKi two secondary plots were constructed.  The first of these was a Dixon plot of 1/Vmax as a 472 
function of [I], from which the value of -αKi can be determined as the x-intercept.  In the second 473 
plot, the slopes of the double-reciprocal lines (from the Lineweaver-Burk plot) are plotted as a 474 
function of [I].  For this plot, the x-intercept will be equal to -Ki.  Combining the information 475 
from these two secondary plots allows determination of both inhibition parameters.  The 476 
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mechanism of DszB inhibition by HBP and DszA inhibition by HBPS could not be determined 477 
due to limited resolution of the HPLC detector.    478 
 479 
Enzyme inhibition model predicts reduction in biocatalyst activity.  A model that 480 
incorporated enzyme inhibition was developed to predict the volumetric desulfurization rate in 481 
biphasic (oil-water) BDS experiments (See Supplemental Material for model equations).  The 482 
model accounted for DBT and HBP in three components: oil, water and cytoplasm.  The two 483 
pathway intermediates, DBTO2 and HBPS, were assumed to only be present in the cytoplasm.  484 
The three major inhibitory interactions by HBP on DszA, DszB and DszC were taken into 485 
account.  The fourth major inhibitory interaction, the inhibition of DszC by HBPS, was ignored 486 
for simplicity.  DszD activity was assumed to not be limiting and was therefore excluded from 487 
the model.  Loss of biocatalyst activity unrelated to HBP accumulation was also taken into 488 
account in the model through an exponential decay constant, kd (See Supplemental Material).  489 
Concentrations of DszA, DszB and DszC were assumed to be all the same and equal to E0.  E0 490 
was the only floating parameter in the model. The value of E0 was obtained by allowing its value 491 
to vary until the initial desulfurization rate predicted by the model matched the measured 492 
desulfurization rate.  The value of E0 obtained was 15 mg/mL, so that the total concentration of 493 
desulfurization enzymes in the cytoplasm was 45 mg/mL.  This value is of the same order as the 494 
total cytoplasmic concentration of protein, which has been reported to be approximately 200 495 
mg/mL (22). 496 
The first step in the biphasic BDS experiments was growth of biocatalyst in a 4L 497 
bioreactor to a cell density of 29-35 g DCW/L.  Next, 10 % vol/vol hexadecane containing 498 
100,000 μM DBT was added to the bioreactor.  The desulfurization rate of DBT in the bioreactor 499 
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was monitored thereafter from the measured concentrations of DBT and HBP in the hexadecane 500 
and aqueous phases.  For the first two hours after hexadecane addition, the mixing speed was 501 
maintained at 200 RPM.  The mixing speed was increased to 500 RPM thereafter to minimize 502 
mass transport limitations in the system.  The enzyme inhibition model was used to predict the 503 
desulfurization rate only after the shift in mixing speed to 500 RPM.  The model predicts the 504 
concentration of HBP in the oil and water phase and the volumetric desulfurization rate 505 
accurately (Figures 6A, 6B and 6C).  The coefficient of determination (R2) between the model 506 
and the data was calculated to be 0.96 using the MATLAB® function corr(X,Y). 507 
 508 
Discussion 509 
Dose-response experiments were performed to investigate the potential inhibitory effect of the 510 
various intermediates in the 4S pathway on the desulfurization enzymes.  Four major inhibitory 511 
interactions were identified, all of which had IC50 values under 110 μM.  Three of the four major 512 
inhibitory interactions were carried out by HBP.  HBP was found to inhibit DszA, DszB and 513 
DszC with IC50 values of 60, 110 and 50 uM, respectively. The fourth major inhibitory 514 
interaction identified is the inhibition of DszC monooxygenase by HBPS.  This interaction is the 515 
strongest of the four since it has the lowest IC50 value of 15 μM. HBPS concentration during the 516 
four-component BDS experiments was not measured in this work.  The IC50 values of HBP on 517 
the desulfurization enzymes are all significantly lower than the minimum cytoplasmic HBP 518 
concentration estimated during the four-component BDS experiments, which was 260 μM.  This 519 
suggests that enzyme inhibition by HBP was responsible for the reduction in biocatalyst activity 520 
during the four-component BDS experiments, even in the presence of 50 g/L of HBP-selective 521 
resin (Dowex ® Optipore SD-2).  In the n-butanol fermentation by Clostridium acetobutylicum 522 
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ATCC 824, n-butanol productivity was increased two-fold upon addition of Dowex® Optipore 523 
SD-2 to the medium (15).  However, the n-butanol toxicity threshold of Clostridium is generally 524 
considered to be about 1.3% (wt./vol.), which is approximately 180 mM (15).  The fact that the 525 
inhibitory levels of HBP on the R. erythropolis IGTS8 desulfurization enzymes are at least 3 526 
orders of magnitude smaller than the toxicity levels of n-butanol on Clostridium might explain 527 
why n-butanol productivity by Clostridium was enhanced upon addition of Dowex ® Optipore 528 
SD-2 while HBP productivity by R.erythropolis IGTS8 was not enhanced. 529 
In another study, R. erythropolis IGTS8 lysates were supplied with 200 μM DBT initially 530 
and the concentrations of DBT, DBTO2, HBPS and HBP were monitored over time (4).  After 10 531 
minutes, all DBT was depleted, the HBPS concentration was approximately 130 μM and the 532 
HBP concentration was approximately 50 μM (4).  From 10 to 60 minutes, the HBPS 533 
concentration decreased steadily from 130 to 0 μM and the HBP concentration increased from 50 534 
to 200 μM.  No DBTO2 was detected at any time (4).  All of these results agree with the kinetic 535 
data obtained in this work.  First of all, since the kcat of DszA is approximately 7 times that of 536 
DszC (Table II), DBTO2 consumption rate is expected to be significantly greater than its 537 
generation rate, which agrees with the fact that no DBTO2 was detected.  Second, the buildup of 538 
HBPS within the first 10 min is consistent with the fact that its consumption rate (DszB kcat = 1.7 539 
min-1) is significantly slower than its generation rate (DszA kcat = 11.2 min-1) (Table II).  The fact 540 
that the HBP concentration accumulates to over 130 μM within the first few minutes indicates 541 
that DszC would have been severely inhibited by HBPS at that point in time.  As HBPS is 542 
consumed, DszC inhibition by HBPS is relieved but then HBP inhibition of DszC (and DszA and 543 
DszB) become more significant.  Therefore, we expect that during a BDS experiment all four 544 
major inhibitory interactions reported here would be important.  HBPS inhibition of DszC is 545 
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responsible for maintaining the BDS rate low at the beginning of the BDS process when HBP 546 
levels are still low.  Once HBP levels rise, HBP inhibition of DszA, DszB and DszC will be 547 
mostly responsible for inhibition of the BDS rate. 548 
Due to the biocatalyst’s high affinity for HBP relative to the aqueous buffer (PC/W = 60 at 549 
Xr = 0 g/L), the intracellular HBP concentration (CHBP,intracellular) is much higher than the HBP 550 
concentration in the aqueous buffer (CHBP,water).  In previous studies, HBP inhibition in biphasic 551 
(oil-water) BDS experiments has been downplayed due to the partition coefficient of HBP 552 
between oil and water (PO/W) being high (around 40-50) (23).  It has been generally assumed that 553 
since the biocatalyst resides in the aqueous phase, the intracellular concentration of HBP is 554 
similar to the aqueous phase concentration.  This assumption is in part because the biocatalyst’s 555 
affinity for HBP has not been quantified in previous studies.  We have shown that this affinity 556 
for HBP is in par with that of the oil phase.  As a result, HBP retention within the biocatalyst and 557 
HBP inhibition of the desulfurization enzymes is an obstacle even in biphasic BDS experiments. 558 
 The affinity of the biocatalyst for HBP is an intrinsic property of the biocatalyst and will 559 
likely vary depending on the biocatalyst employed.  Interactions between cyclic hydrocarbons 560 
and biological membranes have been previously investigated (24).  The partition coefficients of a 561 
range of cyclic hydrocarbons (including aromatics) between liposomes prepared from E. coli 562 
phospholipids and an aqueous phosphate buffer were measured.  From these measured partition 563 
coefficients, a correlation for predicting the partition coefficient of any cyclic hydrocarbon 564 
between the liposome (membrane) and the aqueous buffer (PM/B) based on the octanol-water 565 
partition coefficient (PO/W) of that cyclic hydrocarbon was developed.  The liposome-buffer 566 
partition coefficient of HBP is predicted to be log(PM/B) = 2.2 given the known value of the 567 
octanol-water partition coefficient log(PO/W) = 3.09 (25).  This is in good agreement with the 568 
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value of the partition coefficient of HBP between the biocatalyst and the buffer measured in this 569 
work of log(PC/W) = 1.8-2.2 (Table I).  The liposomes prepared by Sikkema et al (1994) are 570 
representative of the cytoplasmic membrane of a gram-negative bacterium.  R. erythropolis, 571 
being a gram-positive bacteria, has a thin cytoplasmic membrane surrounded by a thick cell wall 572 
made mostly of peptidoglycan sturcutre and mycolic acids (10).  The fact that the value of 573 
log(PC/W) measured in this study agrees well with the predicted value of log(PM/B) suggests that 574 
HBP retained by R. erythropolis IGTS8 might reside mostly within the cytoplasmic membrane as 575 
opposed to the cell wall, which is structurally very different.  This idea agrees with the 576 
mechanism of DBT to HBP conversion during the BDS process.  When DBT is added 577 
exogenously, it is transported into the cell (likely by passive diffusion).  Inside the cytoplasm, the 578 
DBT is transformed to HBP via the 4S pathway and then the HBP will interact first with the 579 
cytoplasmic membrane as it attempts to exit the cell. 580 
 581 
Conclusions 582 
In this work, the mechanism of biocatalyst inhibition in the BDS of DBT was investigated.  583 
Retention of the final product HBP during the BDS process to concentrations in the hundreds of 584 
μM range or higher leads to inhibition of the three enzymes in the linear part of the 4S pathway.  585 
These three enzymes DszA, DszB and DszC have IC50 values with respect to HBP of 60, 110 586 
and 50 μM, respectively.  Host engineering to reduce retention of HBP might mitigate inhibition 587 
of the 4S pathway by HBP.  This poses a formidable challenge as it has been suggested that the 588 
cytoplasmic membrane, which is ubiquitous in nature, may be responsible for HBP retention 589 
within the biocatalyst.  Protein engineering might also be explored as a means to overcome 590 
inhibition of the pathway enzymes. 591 
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Nomenclature 597 
CHBP – concentration of HBP (μM) 598 
[E0] – total enzyme concentration 599 
fcytoplasm – volume fraction of a single cell occupied by cytoplasm 600 
fcell wall – volume fraction of a single cell occupied by cell wall 601 
[I] – Inhibitor concentration (μM) 602 
IC50 – inhibitor concentration that reduces enzyme’s activity by 50% 603 
kcat – enzyme turnover number (min-1) 604 
Km – Michaelis constant (μM) 605 
KSI – substrate inhibition constant (μM) 606 
Ki – enzyme inhibition constant 607 
Lc – loading of HBP on the cells (mg HBP/g DCW) 608 
Lr – loading of HBP on resin (mg HBP/g resin)  609 
mc – mass of cells (g DCW) 610 
mr – mass of resin (g) 611 
PO/W – HBP partition coefficient between hexadecane and aqueous buffer 612 
PC/W – HBP partition coefficient between biocatalyst and aqueous buffer 613 
PR/W – HBP partition coefficient between resin and aqueous buffer 614 
PC/O – HBP partition coefficient between biocatalyst and hexadecane 615 
PR/C – HBP partition coefficient between resin and biocatalyst 616 
PR/O – HBP partition coefficient between resin and hexadecane 617 
Pcell wall/W – HBP partition coefficient between the cell wall and aqueous buffer 618 
Pcytoplasm/W – HBP partition coefficient between cytoplasm and aqueous buffer  619 
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Rcell – radius of the cell (μm) 620 
[S] – Substrate concentration (μM) 621 
Vtotal – total volume of oil, water and resin in HBP adsorption by resin experiments (L) 622 
Vmax – maximum enzyme activity (nmole product/g enzyme/min) 623 
W – thickness of the cell wall (nm) 624 
Xr – resin concentration (g/L) 625 
α – parameter that reflects effect of inhibitor on enzyme’s affinity for its substrate 626 
ν0 – enzyme’s activity in the absence of inhibitor (nmole product/g enzyme/min) 627 
 628 
629 
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Tables 700 
Table I. Comparison of partition coefficients between the four different components in the four component 
BDS experiments in the presence of the resin Dowex® Optipore SD-2. 
Resin concentration 
(g/L) PC/O PC/W PO/W PR/C PR/O PR/W 
0 1 60 52 - - - 
10 1 47 42 88 99 4116 
50 3 160 54 99 296 15906 
Resin concentration 
(g/L) log PC/O log PC/W log PO/W log PR/C log PR/O log PR/W 
0 0.1 1.8 1.7 - - - 
10 0.0 1.7 1.6 1.9 2.0 3.6 
50 0.5 2.2 1.7 2.0 2.5 4.2 
C – cells 
O – oil 
W – water 
R – resin 
 701 
Table II.  Summary of the main properties of the Dsz enzymes purified in this work including the molecular weight 
(MW), stock concentration and measured kinetic constants.  
 This work Other authors 
Enzyme Mw 
(kDa) 
Stock 
Concentration 
(mg/mL) 
kcat 
(min-1) 
Km (μM) 
 
kcat/Km  
(μM-1 min-1) 
kcat (min-1) Km (μM) 
DszA 49.6 1.3 11±2 3.6 ± 0.5 
 
3.1 “about 60”a “approx. 1”a 
DszB 39.0 1.2 1.7±0.2 1.3 ± 0.3 1.3 1.3 ± 0.07 b 0.90 ± 0.15 b 
DszC 45.0 6.1 1.6±0.3 1.4 ± 0.3, KSI = 
3 ± 0.2 μM 
 
1.1 n/a “less than 5”a 
DszD 25.0 4.7 760±10 114 ± 5 
(NADH), 7.3 ± 
0.5 (FMN) 
6.7 (NADH), 
100 (FMN) 
~300 c 208 (NADH), 10.8 
(FMN) d 
a Strain used was R. erythropolis IGTS8 (4) 
b Strain used was R. erythropolis IGTS8 (6) 
c Calculated estimate based on data in (4).  Strain used was R. erythropolis IGTS8  
d Strain used was R. erythropolis D-1 (21) 
 702 
Table III.  Summary of inhibition parameters for the four major inhibitory interactions 
including the mechanism of inhibition, the KI, α and IC50 values.
Enzyme Inhibitor Mechanism KI (μM) α IC50 (μM) 
DszA HBP Not determined n/a n/a 60 ± 5 
DszB HBP Not determined n/a n/a 110 ± 10 
DszC HBPS Non-competitive 13.5 0.13 15 ± 2 
DszC HBP Non-competitive 40 0.4 50 ± 5 
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Figure Captions 705 
Figure 1.  The four-step biodesulfurization 4S pathway.  The first two steps, catalyzed by both 706 
DszC and DszD, are the conversion of DBT to DBT-sulfoxide (DBTO) and then to DBT-sulfone 707 
(DBTO2).  The third step, catalyzed by both DszA and DszD, is the conversion of DBTO2 to 708 
HBPS.  The final step is the conversion of HBPS to HBP by DszB. 709 
 710 
Figure 2.  (A) – Specific loading of HBP (white) and DBT (black) by the various resins tested at 711 
a resin concentration of 10 g/L from a 0.50 vol./vol. hexadecane-water solution containing 10 712 
mM DBT and 10 mM HBP initially. (B) – Total HBP produced (white) and cytoplasmic HBP 713 
concentration (black) in four-component BDS experiment at 15.5 g DCW/L, oil fraction 0.50 714 
vol/vol and 10 mM DBT.  Specific HBP loadings are shown above black columns. Data shown 715 
are the average and standard deviations of 3 replicates. 716 
 717 
Figure 3.  Enzyme kinetics for DszA (A), DszB (B), DszC (C), and DszD (D).  Diamonds 718 
represent data and solid lines represent Michaelis-Menten model fits for DszA, DszB and DszD 719 
and substrate inhibition model for DszC. Data shown are the average and standard deviations of 720 
3 replicates. 721 
 722 
Figure 4.  Normalized desulfurization enzyme activity at different inhibitor concentrations for 723 
the four major inhibitory interactions identified in the 4S pathway. (A) – DszA inhibition by 724 
HBP has an IC50 of 60 ± 5 μM; (B) – DszB inhibition by HBP has an IC50 of 110 ± 10 μM; (C) – 725 
DszC inhibition by HBPS has an IC50 of 15 ± 2 μM; (D) – DszC inhibition by HBP has an IC50 726 
of 50 ± 5 μM. Data shown are the average and standard deviations of 3 replicates. 727 
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 728 
Figure 5.  Non-competitive inhibition of DszC by HBPS and HBP. (A) – DszC activity at a 729 
range of DBT substrate concentrations from 0-5 μM and HBPS concentrations of 0 μM (closed 730 
diamonds), 5 μM (closed squares), 25 μM (closed triangles) and 50 μM (crosses).  (B) – DszC 731 
activity at a range of DBT substrate concentrations from 0-5 μM and HBP concentrations of 0 732 
μM (closed diamonds), 100 μM (closed squares), 500 μM (closed triangles). Solid lines are 733 
model fits from equation 15. 734 
 735 
Figure 6.  Enzyme inhibition model predictions for BDS bioreactor experiment. (A) – 736 
Volumetric desulfurization rate data (circles) and model prediction (line).  (B) – Concentration of 737 
HBP in the oil phase data (circles) and model (line).  (C) – Concentration of HBP in the water 738 
phase data (circles) and model (line).  Data shown are the average and standard deviations of 3 739 
replicates. 740 
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Figure 2.  (A) – Specific loading of HBP (white) and DBT (black) by the various resins tested at 
a resin concentration of 10 g/L from a 0.50 vol./vol. hexadecane-water solution containing 10 
mM DBT and 10 mM HBP initially. (B) – Total HBP produced (white) and cytoplasmic HBP 
concentration (black) in four-component BDS experiment at 15.5 g DCW/L, oil fraction 0.50 
vol/vol and 10 mM DBT.  Specific HBP loadings are shown above black columns. Data shown 
are the average and standard deviations of 3 replicates. 
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Figure 3. Enzyme kinetics for DszA (A), DszB (B), DszC (C), and DszD (D).  Diamonds 
represent data and solid lines represent Michaelis-Menten model fits for DszA, DszB and DszD 
and substrate inhibition model for DszC. Data shown are the average and standard deviations of 
3 replicates. 
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Figure 4.  Normalized desulfurization enzyme activity at different inhibitor concentrations for 
the four major inhibitory interactions identified in the 4S pathway. (A) – DszA inhibition by 
HBP has an IC50 of 60 ± 5 μM; (B) – DszB inhibition by HBP has an IC50 of 110 ± 10 μM; (C) – 
DszC inhibition by HBPS has an IC50 of 15 ± 2 μM; (D) – DszC inhibition by HBP has an IC50 
of 50 ± 5 μM.  Data shown are the average and standard deviations of 3 replicates. 
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Figure 5.  Non-competitive inhibition of DszC by HBPS and HBP. (A) – DszC activity at a 
range of DBT substrate concentrations from 0-5 μM and HBPS concentrations of 0 μM (closed 
diamonds), 5 μM (closed squares), 25 μM (closed triangles) and 50 μM (crosses).  (B) – DszC 
activity at a range of DBT substrate concentrations from 0-5 μM and HBP concentrations of 0 
μM (closed diamonds), 100 μM (closed squares), 500 μM (closed triangles).  Solid lines are 
model fits from equation 15. 
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Figure 6.  Enzyme inhibition model predictions for BDS bioreactor experiment. (A) – 
Volumetric desulfurization rate, VBDS, data (circles) and model prediction (line).  (B) – 
Concentration of HBP in the oil phase data (circles) and model (line).  (C) – Concentration of 
HBP in the water phase data (circles) and model (line). Data shown are the average and standard 
deviations of 3 replicates. 
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